<DOC>
	<DOC>NCT02716857</DOC>
	<brief_summary>The purpose of this study is to determine the analgesic efficacy of Egalet-002 twice daily (BID) in patients with moderate-to-severe chronic low back pain</brief_summary>
	<brief_title>Efficacy and Safety of Egalet-002 in Patients With Moderate-to-Severe Chronic Low Back Pain</brief_title>
	<detailed_description />
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<mesh_term>Oxycodone</mesh_term>
	<criteria>Is an Englishspeaking man or woman between 18 and 75 years of age who has given written informed consent. Has a clinical diagnosis of moderatetosevere low back pain (Quebec Task Force Class 1 to 3) for ≥6 months. Is opioid naïve (ie, taking &lt;20 mg oxycodone/day or opioid equivalent) or is opioid experienced (ie, taking a dose between 20 and 240 mg [inclusive] oxycodone/day or opioid equivalent) for management of moderatetosevere CLBP at least 14 days prior to screening and will, in the opinion of the investigator, continue to require opioid therapy (between 20 and 240 mg oxycodone/day, inclusive) for management of moderatetosevere CLBP for the duration of the study. Has stable health, as determined by the investigator, If female, the patient is currently not pregnant, not breastfeeding, nor attempting to become pregnant (for 30 days before screening and throughout the duration of the study), or is of nonchildbearing potential Has cancerrelated pain. Has a history of receiving &gt;240 mg oxycodone (or equivalent) daily within 30 days before screening. Has a lumbar spinal infusion pump in use or used within 6 months before screening. Has clinically unstable cardiac disease (including atrial fibrillation, symptomatic bradycardia, unstable congestive heart failure, or active myocardial ischemia) Has positive urine drug toxicity screen for illegal or nonprescribed drugs Has current (or history of within the last 5 years prior to screening) drug dependence or substance abuse disorder according to Diagnostic and Statistical Manual of Mental Disorders, 5th Edition, Text Revision criteria (excluding nicotine). Has positive result for cannabinoids (even if legally prescribed). Has a history of attempted suicide.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>